Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05219149 · ClinicalTrials.gov registry record
CNS Qualitative Interview
A clinical trial of Central Nervous System Cancer, sponsored by University of Colorado, Denver.
- Recruiting
- Registry status
- 20
- Enrollment target
- 1
- Study location
NCT05219149: Recruiting study of Central Nervous System Cancer, sponsored by University of Colorado, Denver.
NCT05219149 is a study of Central Nervous System Cancer that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 20 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05219149, a study of Central Nervous System Cancer, is actively recruiting participants, sponsored by University of Colorado, Denver.
- RECRUITING
- Registry status
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
Explore factors involved in decision making for patients with new or recurrent CNS tumors and their families surrounding treatment planning and clinical trial enrollment.
Primary Outcome
Qualitative interviews with patients and families who are considering treatment options for new or recurrent CNS tumors to identify specific barriers to full participation in treatment and clinical trial enrollment (e.g., transportation, childcare, ancillary expenses). Qualitative interviews will be structured to comprehensively address potential barriers but also open-ended to give patients and families freedom to discuss a wide range of challenges.
Conditions Studied
Interventions
- BEHAVIORAL Qualitative Interviews
Study Locations (1)
Colorado
- Children's Hospital Colorado - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2022-01-03 |
| Est. Completion | 2026-07-23 |
What NCT05219149 shows while recruiting
NCT05219149 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 1 condition, with Central Nervous System Cancer appearing as the primary indexed condition, and to 1 intervention - of which Qualitative Interviews is the first listed.
NCT05219149 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT05219149 about?
NCT05219149 is a clinical study titled "CNS Qualitative Interview". Explore factors involved in decision making for patients with new or recurrent CNS tumors and their families surrounding treatment planning and clinical trial enrollment.
What is the current status of trial NCT05219149?
This trial is currently recruiting. The enrollment target is 20 participants. The study started on 2022-01-03. Estimated completion is 2026-07-23.
What conditions does trial NCT05219149 study?
This clinical trial studies the following conditions: Central Nervous System Cancer.
What interventions are being tested in trial NCT05219149?
The interventions under investigation include: Qualitative Interviews (BEHAVIORAL).
Who is sponsoring clinical trial NCT05219149?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05219149 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Central Nervous System Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI